Sunanda Ghosh Dastidar
Overview
Explore the profile of Sunanda Ghosh Dastidar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
96
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh R, Najmi A, Dastidar S
Pharmacol Rep
. 2017 Jun;
69(4):746-756.
PMID: 28582691
The p38/MK2 pathway regulates a wide range of biological functions, and thus has most been explored as a therapeutic target for inhibition of severe and chronic inflammatory diseases. Till date,...
2.
Singh R, Tandon R, Dastidar S, Ray A
J Asthma
. 2013 Jul;
50(9):922-31.
PMID: 23859232
Objective And Methods: Leukotrienes (LTs) including cysteinyl leukotrienes (CysLTs) and LTB4 are the most potent inflammatory lipid mediators and play a central role in the pathophysiology of asthma and other...
3.
Chakraborty S, Chopra P, Hak A, Dastidar S, Ray A
Expert Opin Investig Drugs
. 2013 Mar;
22(4):499-515.
PMID: 23484858
Introduction: Pulmonary fibrosis (PF) is a progressive fatal disorder and is characterized by alveolar epithelial injury, myofibroblast proliferation, and extracellular matrix remodeling, resulting in irreversible distortion of lung's architecture. Available...
4.
Malhotra S, Deshmukh S, Dastidar S
Expert Opin Ther Targets
. 2012 Feb;
16(2):195-207.
PMID: 22324934
Introduction: The cyclooxygenase (COX) enzyme, which is responsible for the production of prostaglandins (PGs), key mediators of inflammation, may have the potential to become an attractive target for anti-inflammatory therapy....